These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37520890)

  • 1. Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis.
    Karpouzas GA; Papotti B; Ormseth SR; Palumbo M; Hernandez E; Adorni MP; Zimetti F; Budoff MJ; Ronda N
    J Transl Autoimmun; 2023 Dec; 7():100209. PubMed ID: 37520890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis.
    Karpouzas GA; Papotti B; Ormseth SR; Palumbo M; Hernandez E; Adorni MP; Zimetti F; Budoff MJ; Ronda N
    J Transl Autoimmun; 2023 Dec; 7():100206. PubMed ID: 37484708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis.
    Karpouzas GA; Papotti B; Ormseth SR; Palumbo M; Hernandez E; Adorni MP; Zimetti F; Budoff MJ; Ronda N
    J Autoimmun; 2023 Apr; 136():103029. PubMed ID: 36996698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
    Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancy.
    Kockx M; Roberts L; Wang J; Tran C; Brown MA; Kritharides L
    Atheroscler Plus; 2022 Apr; 48():12-19. PubMed ID: 36644562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.
    He Y; Pavanello C; Hutchins PM; Tang C; Pourmousa M; Vaisar T; Song HD; Pastor RW; Remaley AT; Goldberg IJ; Costacou T; Sean Davidson W; Bornfeldt KE; Calabresi L; Segrest JP; Heinecke JW
    Circulation; 2024 Mar; 149(10):774-787. PubMed ID: 38018436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis.
    Karpouzas GA; Papotti B; Ormseth S; Palumbo M; Hernandez E; Adorni MP; Zimetti F; Budoff M; Ronda N
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36113961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
    He Y; Ronsein GE; Tang C; Jarvik GP; Davidson WS; Kothari V; Song HD; Segrest JP; Bornfeldt KE; Heinecke JW
    Circ Res; 2020 Oct; 127(9):1198-1210. PubMed ID: 32819213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
    van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
    J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity.
    van Velzen DM; Adorni MP; Zimetti F; Strazzella A; Simsek S; Sirtori CR; Heijer MD; Ruscica M
    Atherosclerosis; 2021 Apr; 323():44-53. PubMed ID: 33836456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.
    Ahmed MO; Byrne RE; Pazderska A; Segurado R; Guo W; Gunness A; Frizelle I; Sherlock M; Ahmed KS; McGowan A; Moore K; Boran G; McGillicuddy FC; Gibney J
    Diabetologia; 2021 Mar; 64(3):656-667. PubMed ID: 33169205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.
    Shao B; Tang C; Sinha A; Mayer PS; Davenport GD; Brot N; Oda MN; Zhao XQ; Heinecke JW
    Circ Res; 2014 May; 114(11):1733-42. PubMed ID: 24647144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
    Ronsein GE; Hutchins PM; Isquith D; Vaisar T; Zhao XQ; Heinecke JW
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):404-11. PubMed ID: 26681752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary stearic acid and palmitic acid do not differently affect ABCA1-mediated cholesterol efflux capacity in healthy men and postmenopausal women: A randomized controlled trial.
    van Rooijen MA; Plat J; Blom WAM; Zock PL; Mensink RP
    Clin Nutr; 2021 Mar; 40(3):804-811. PubMed ID: 32900520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib.
    Nicholls SJ; Ruotolo G; Brewer HB; Kane JP; Wang MD; Krueger KA; Adelman SJ; Nissen SE; Rader DJ
    J Am Coll Cardiol; 2015 Nov; 66(20):2201-2210. PubMed ID: 26564598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.
    El Khoudary SR; Hutchins PM; Matthews KA; Brooks MM; Orchard TJ; Ronsein GE; Heinecke JW
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3419-28. PubMed ID: 27399353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events.
    Magnoni M; Andreini D; Pirillo A; Uboldi P; Latini R; Catapano AL; Maggioni AP; Norata GD;
    Ann Med; 2022 Dec; 54(1):1036-1046. PubMed ID: 35438019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
    Asztalos BF; Hauser TH; Goldfine AB; Welty FK; Horvath KV; Schaefer EJ
    Atherosclerosis; 2022 Mar; 345():1-6. PubMed ID: 35183903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired cholesterol efflux capacity in patients with Helicobacter pylori infection and its relation with inflammation.
    Fallah S; Marsche G; Mohamadinarab M; Mohassel Azadi S; Ghasri H; Fadaei R; Moradi N
    J Clin Lipidol; 2021; 15(1):218-226.e1. PubMed ID: 33250430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism.
    Ronda N; Greco D; Adorni MP; Zimetti F; Favari E; Hjeltnes G; Mikkelsen K; Borghi MO; Favalli EG; Gatti R; Hollan I; Meroni PL; Bernini F
    Arthritis Rheumatol; 2015 May; 67(5):1155-64. PubMed ID: 25605003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.